Osteoarthritis

Personalised gait retraining for medial compartment knee osteoarthritis: a randomised controlled trial

Lancet RheumatolPublished Randomised controlled trial

Primary result · Medial knee pain (NRS), changeResult — go to the resultBetween-group difference −1.2 95% CI −1.9 to −0.5

Authors' conclusion

Personalised foot angle modifications improve pain, reduce knee loading, and might slow osteoarthritis progression, making them a promising non-surgical treatment option for some individuals with medial compartment knee osteoarthritis.

Study context

Population
Adults (≥18 years) with symptomatic mild-to-moderate medial compartment knee OA, Stanford University, CA, USAmean age 64.4 years
Participants
68 adults
Comparison
Personalised foot progression angle modification vs sham
  • Interventionn = 34
  • Shamn = 34reference
Primary endpoint
Co-primary: change in medial knee pain (NRS) and medial knee loading (knee adduction moment peak)
Follow-up
1 year
Methodological detailssingle-centre, parallel-group, sham-controlled, participant- and analyst-masked
  • Single-centre
  • Parallel-group
  • Sham-controlled
  • Participant- and analyst-masked

Primary result

Medial knee pain (NRS), change

Between-group difference

−1.2

95% CI −1.9 to −0.5

P = 0.0013

Interventionvs Sham
between-group difference −1.2 (95% CI −1.9 to −0.5); P = 0.0013

As reported in the abstract

Secondary outcomes

OutcomeBetween-group difference (% bodyweight × height) (95% CI)P value
Co-primary: knee adduction moment peak, change · 1 year−0.26 (−0.39 to −0.13)P = 0.0001
OutcomeBetween-group difference (ms) (95% CI)
Medial compartment cartilage microstructure (MRI T1ρ), change · 1 year−3.74 (−6.42 to −1.05)

Cartilage microstructure (MRI T2), change · 1 year

No significant between-group differences in T2

Safety

Dropout due to increased knee pain

Severe adverse events

No severe adverse events

Original publication

Personalised gait retraining for medial compartment knee osteoarthritis: a randomised controlled trial. Lancet Rheumatol. Published 12 August 2025. doi:10.1016/s2665-9913(25)00151-1

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.